From our survey

Finding ketamine therapy care near you without guessing

One group in our survey almost never gets written about. We asked 443 adults to name their first stop for ketamine-type care for depression or PTSD, and 5 percent chose the most honest answer on the list: they would not know where to start.

It is the smallest number in that question and the truest. Everyone else named a door. This guide is for people standing in a hallway where none of the doors are labeled.

The same data carries encouraging news. Asked for a first reaction, 51 percent of respondents landed somewhere open (34 percent cautious but open, plus 18 percent who felt hopeful or curious), while 9 percent reacted negatively. Cautious but open was the single largest group, so it is likely where you are too.

Step one: begin with the doctor you already have

In our results, 56 percent said their first stop would be primary care. Psychiatrists and other mental health clinicians came second at 23 percent, with online searching at 12 and asking a friend at 1.

Follow the majority, and not out of politeness. The approved form of this treatment is reached through a prescriber, and whether you qualify depends on what you have already taken, at what dose, and for how long. That record lives in your chart. Starting with a stranger means rebuilding it from memory.

No regular doctor? Any prescriber who can take a full history will do: a psychiatric nurse practitioner, a community health center, or a hospital's behavioral health intake line.

Step two: search the way you actually feel

We gave people a blank box and asked what they would really type when looking for help. Among 319 replies, almost none contained a drug name. They wrote "how to cope with my anxiety," "therapist near me," "someone please help me," "help with depression."

Search in the words you would use with a friend, then run a narrower search for certified locations once step three gives you the vocabulary.

Step three: learn which of the three things called ketamine you are looking at

• Esketamine, sold as Spravato, holds FDA approval for depression that has not improved on standard treatment. You take each dose inside a certified office, staff observe you afterward, and none of it goes home with you.
• Generic IV ketamine at a clinic uses an approved anesthetic off label for depression. That is legal and common, but it stands on different regulatory ground and often a different way of paying.
• Ketamine prescribed through a telehealth service for home use is a third model, farthest from monitoring, and it deserves your hardest questions before you enroll.

Choose which one you want before calling anyone, because a request for "ketamine treatment" lands you with whatever version that office happens to sell. If it helps to see how a clinic offering the supervised, approved version describes it, Brain Recovery Centers has a plain page about Spravato.

Step four: sort out coverage before you commit to a schedule

Money was the loudest signal in our survey. When respondents picked their top two provider criteria, insurance coverage was on the list for 85 percent, and a nearby location lagged at 43 percent. Coverage would be decisive for 22 percent and weigh heavily for another 43 percent, 65 percent combined. Given insured care with extra steps or self-pay with a quicker start, half (51 percent) took the steps; the rest split nearly evenly, 23 percent paying and 26 percent undecided.

So make the dull call before the hopeful one. Ask your plan whether the treatment falls under the medical or pharmacy benefit, whether prior authorization applies, how many documented medication trials they require, which certified sites are in network, and what each session costs after the deductible. If you are turned down, ask how to appeal; a first denial is not the end.

Step five: decide what delivery you actually want

On format, 44 percent of respondents preferred a clinic in person, 22 percent telehealth at home, and 23 percent a clinic start with home later; 11 percent were fine with any of them.

Convenience and oversight pull against each other. A supervised visit means appointments, a monitoring period you cannot skip, and a ride every time, plus a trained person nearby if something goes sideways. Home care is easier to keep up and harder to supervise. The right choice is the one you can still keep in week six and that your clinician thinks fits your history.

Step six: ask what the drug-free options are

For 64 percent of respondents, being free of medication mattered, while only 25 percent knew what transcranial magnetic stimulation, or TMS, is. Half the sample sat in one bucket: drug-free matters to me, and I have never heard of that treatment.

Ask what non-drug approaches exist for your situation, what evidence supports each, and whether your plan pays.

Step seven: questions for any treatment center before you book

• Which of the three do you provide, and is this location certified for the approved product?
• Who prescribes, and can I verify the license with the state board?
• What monitoring happens on site, and what is the plan if my blood pressure climbs or a session goes badly?
• Do you want records of my past medication trials? A place that wants none of your history is telling you something.
• What is the full cost, what is billed to insurance, and what am I committing to past the first few visits?
• How do you decide someone is not a candidate?

This page is not medical advice and endorses no treatment, and no one can promise a result. Whether any of it fits your body, history, and other medications is a clinician's judgment.

One more thing matters more than the rest. If depression has started to include thoughts of ending your life, that cannot sit in a referral queue. A call or text to 988 from anywhere in the country reaches a trained Lifeline counselor at any hour, free and confidential. Tell one human being today, even if the sentence comes out wrong.

Methodology

This site's publisher commissioned and funded the research. Pollfish fielded this first-party survey on its consumer panel, finishing on June 23, 2026. It was completed by 443 members of the general public, ages 18 to 64, living across ten states of the Midwest. Everyone consented first. Multi-select lists add past 100. The numbers come from the panel's validated, final data.